A double-blind, randomized, placebo controlled, parallel group study to compare the safety and efficacy of an olmesartan medoxomil based treatment regimen to placebo in patients with stage I and stage II hypertension.
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2018
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 26 Jan 2010 Actual patient number (278) added as reported by ClinicalTrials.gov.
- 26 Jan 2010 Actual end date (October 2007) added as reported by ClinicalTrials.gov.
- 10 Dec 2007 Status changed from recruiting to completed.